Skip to main content
Willis Towers Watson PLC (WTW)
Insurance Financial
Stock AI

Healthcare Costs Set to Rise: WTW Projects Double-Digit Increases for 2026

Last updated: November 11, 2025
Taurigo

In a recently released report, Willis Towers Watson PLC (WTW) unveiled alarming projections for global healthcare costs, forecasting a continual rise into 2026. The 2026 Global Medical Trends report indicates that the average cost of medical health benefits is expected to increase by 10.3% globally, following increases of 10% in 2025 and 9.5% in 2024. This trend highlights the persistent inflationary pressures affecting healthcare systems worldwide.

1. Regional Variations in Healthcare Cost Increases

The report provides a regional breakdown of expected healthcare cost increases, revealing significant disparities across different areas:

  • Asia Pacific is projected to experience the highest cost increase at 14.0%.
  • Latin America anticipates a sharp rise from 10.5% in 2025 to 11.9% in 2026.
  • Middle East and Africa will see healthcare costs rise by 11.3%.
  • In contrast, North America and Europe are expecting slight declines in their medical inflation rates, with North America projected at 9.2% down from 9.4%, and Europe at 8.2% down from 8.3%.

In the United States, the healthcare cost is expected to reach 9.6% in 2026, a slight decrease from 9.7% in 2025 but still significantly higher than the 7.6% recorded in 2024.

2. Factors Driving Healthcare Inflation

WTW's survey of health insurers revealed that more than half (55%) of insurers anticipate that the elevated costs will persist for over three years. Several key factors contribute to this ongoing inflation:

  1. New Medical Technologies: Cited by 74% of insurers as the primary driver of medical inflation.
  1. Decline of Public Health Systems: Identified by 52% of insurers as a significant concern.
  1. Advancements in Pharmaceuticals: Noted by 49% of insurers, reflecting the ongoing evolution in healthcare delivery.

Linda Pham, WTW’s global health and risk leader, emphasized that despite regional variations in healthcare provision, rising medical costs represent a universal challenge. However, she noted that investments in technologies, including artificial intelligence, may present long-term opportunities for mitigating these costs.

3. Disease-Driven Cost Increases

From a disease perspective, cancer emerges as the leading condition driving global medical costs, with 57% of insurers identifying it as the fastest-growing and most expensive diagnosis. Notably, there has been an increase in cancer incidence among individuals under 40, a concerning trend that underscores the need for enhanced preventive measures.

Cardiovascular conditions follow closely, cited by 50% of insurers, while behavioral health issues rank third at 37%. These statistics highlight the pressing need for strategic management of healthcare expenses, particularly for multinational employers.

4. Strategies for Employers

Courtney Stubblefield, managing director of Health & Benefits at WTW, discussed the necessity for employers to navigate healthcare inflation strategically. Recommendations include:

  • Investing in employee education about health benefits usage.
  • Raising awareness of prevention programs for prevalent diseases, particularly cancer.
  • Optimizing mental health coverage and introducing flexible benefits.

Stubblefield emphasized that through careful management and a balanced short- and long-term approach, employers can maximize the value of their healthcare benefits while effectively managing cost inflation.

5. Conclusion

As global healthcare costs are projected to soar into 2026, WTW's report serves as a crucial wake-up call for businesses and policymakers alike. With rising medical costs affecting every region, stakeholders must strategize effectively to mitigate the impact on employees and organizational budgets. The insights provided by WTW underscore the importance of proactive measures in addressing the complexities of healthcare inflation in today's evolving landscape.

You may also be interested in:
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.